Abstract

Continuous disk-stack centrifugation is typically used for the removal of cells and cellular debris from mammalian cell culture broths at manufacturing-scale. The use of scale-down methods to characterise disk-stack centrifugation performance enables substantial reductions in material requirements and allows a much wider design space to be tested than is currently possible at pilot-scale. The process of scaling down centrifugation has historically been challenging due to the difficulties in mimicking the Energy Dissipation Rates (EDRs) in typical machines. This paper describes an alternative and easy-to-assemble automated capillary-based methodology to generate levels of EDRs consistent with those found in a continuous disk-stack centrifuge. Variations in EDR were achieved through changes in capillary internal diameter and the flow rate of operation through the capillary. The EDRs found to match the levels of shear in the feed zone of a pilot-scale centrifuge using the experimental method developed in this paper (2.4×105 W/Kg) are consistent with those obtained through previously published computational fluid dynamic (CFD) studies (2.0×105 W/Kg). Furthermore, this methodology can be incorporated into existing scale-down methods to model the process performance of continuous disk-stack centrifuges. This was demonstrated through the characterisation of culture hold time, culture temperature and EDRs on centrate quality.

Highlights

  • Understanding a product’s key quality attributes and its process of manufacture through the use of design spaces is a regulatory requirement for biopharmaceutical manufacturers [1]

  • The fast protein liquid chromatography (FPLC) instrument had the utility of generating performance feedback through back pressure readings which enabled the calculation of Energy dissipation rate (EDR) (Eq 1)

  • Studies were conducted to show that the Capillary shear device (CSD) using the automated methodology developed in this paper had the ability to process cell culture to create multiple levels of shear through changes in capillary diameter and operational flow rates

Read more

Summary

Introduction

Understanding a product’s key quality attributes and its process of manufacture through the use of design spaces is a regulatory requirement for biopharmaceutical manufacturers [1].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call